DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ANTI-PR1/HLA-A2 MONOCLONAL ANTIBODY HU8F4
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ANTI-PR1/HLA-A2 MONOCLONAL ANTIBODY HU8F4
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-2748
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis C
Unknown
MK-2748
×
Maximum Phase:
1
First Approval:
None
UNII:
7YM030A71C
Molecule Type:
Small molecule
Molecular Formula:
C42H56N6O10S
Molecular Weight:
837.01
AlogP:
3.84
PSA:
204.33
HBD:
3.0
HBA:
#RotB:
8.0
Source:
MURIZATOCLAX
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes
Unknown
MURIZATOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C42H57ClN4O5S
Molecular Weight:
765.46
AlogP:
6.44
PSA:
91.42
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PRI-724
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Neoplasms; Colorectal Neoplasms
CBP/beta catenin inhibitor
PRI-724
×
Maximum Phase:
1
First Approval:
None
UNII:
43Y934BBZ6
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KB-004
1
Antibody
Investigational
Unknown
Unknown
Glioblastoma; Myelodysplastic Syndromes; Primary Myelofibrosis
Ephrin type-A receptor 3 inhibitor
KB-004
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-8165
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD-8165
×
Maximum Phase:
1
First Approval:
None
UNII:
7WO8I5IY24
Molecule Type:
Small molecule
Molecular Formula:
C23H21ClFN7O4
Molecular Weight:
513.92
AlogP:
2.35
PSA:
131.67
HBD:
1.0
HBA:
#RotB:
8.0
Source:
CYC065
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CYC065
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MUBRITINIB
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Kidney Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms
Receptor protein-tyrosine kinase erbB-2 inhibitor
MUBRITINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
V734AZP9BR
Molecule Type:
Small molecule
Molecular Formula:
C25H23F3N4O2
Molecular Weight:
468.48
AlogP:
6.06
PSA:
65.97
HBD:
0.0
HBA:
#RotB:
10.0
Source:
PELCITOCLAX
1
Small molecule
Investigational
Unknown
Unknown
Neuroendocrine Tumors
Unknown
PELCITOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C57H66ClF4N6O11PS4
Molecular Weight:
1281.87
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
UBAMATAMAB
1
Antibody
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Ovarian Neoplasms
Unknown
UBAMATAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RECOMBINANT HUMAN HEPATOCYTE GROWTH FACTOR
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
RECOMBINANT HUMAN HEPATOCYTE GROWTH FACTOR
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOTAMTATE PB-212
1
Unknown
Investigational
Unknown
Unknown
Neuroendocrine Tumors
Unknown
DOTAMTATE PB-212
×
Maximum Phase:
1
First Approval:
None
UNII:
E9N7QV53AK
Molecule Type:
Unknown
Molecular Formula:
C65H91N17O16PbS2
Molecular Weight:
1642.67
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RUNIMOTAMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
RUNIMOTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BOTENSILIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
BOTENSILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY-3076226
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LY-3076226
×
Maximum Phase:
1
First Approval:
None
UNII:
GP2L3N7FIM
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-830216
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
BMS-830216
×
Maximum Phase:
1
First Approval:
None
UNII:
ISL723GVQ8
Molecule Type:
Small molecule
Molecular Formula:
C24H22ClN2O7PS
Molecular Weight:
548.94
AlogP:
5.04
PSA:
120.11
HBD:
2.0
HBA:
#RotB:
9.0
Source:
OTX-008
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OTX-008
×
Maximum Phase:
1
First Approval:
None
UNII:
8JI63CFH5V
Molecule Type:
Small molecule
Molecular Formula:
C52H72N8O8
Molecular Weight:
937.2
AlogP:
2.59
PSA:
166.28
HBD:
4.0
HBA:
#RotB:
24.0
Source:
PA401
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
PA401
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMG-900
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid; Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
AMG-900
×
Maximum Phase:
1
First Approval:
None
UNII:
9R2G075611
Molecule Type:
Small molecule
Molecular Formula:
C28H21N7OS
Molecular Weight:
503.59
AlogP:
6.64
PSA:
111.73
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LITOXETINE
1
Small molecule
Investigational
Unknown
Unknown
Urinary Incontinence
Unknown
LITOXETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
9980ST005G
Molecule Type:
Small molecule
Molecular Formula:
C16H19NO
Molecular Weight:
241.33
AlogP:
3.11
PSA:
21.26
HBD:
1.0
HBA:
#RotB:
3.0
Source:
DCC-2036
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DCC-2036
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VERDINEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VERDINEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
85Q03215IW
Molecule Type:
Small molecule
Molecular Formula:
C18H12F6N6O
Molecular Weight:
442.32
AlogP:
3.99
PSA:
84.73
HBD:
2.0
HBA:
#RotB:
5.0
Source:
11C-MK-3168
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
11C-MK-3168
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VUNAKIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Lupus Nephritis; Spondylitis, Ankylosing; Psoriasis
Unknown
VUNAKIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
Y4U029R8MS
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-1496
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase PLK1 inhibitor
MK-1496
×
Maximum Phase:
1
First Approval:
None
UNII:
CS17H9370C
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAS-116
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TAS-116
×
Maximum Phase:
1
First Approval:
None
UNII:
PLO044MUDZ
Molecule Type:
Small molecule
Molecular Formula:
C25H26N8O
Molecular Weight:
454.54
AlogP:
3.79
PSA:
109.44
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ELINOGREL
1
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases; Myocardial Infarction
Purinergic receptor P2Y12 antagonist
ELINOGREL
×
Maximum Phase:
1
First Approval:
None
UNII:
915Y8E749J
Molecule Type:
Small molecule
Molecular Formula:
C20H15ClFN5O5S2
Molecular Weight:
523.96
AlogP:
3.09
PSA:
142.16
HBD:
4.0
HBA:
#RotB:
5.0
Source:
L-ARABINOSE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
L-ARABINOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
UO2PIV2K4C
Molecule Type:
Small molecule
Molecular Formula:
C5H10O5
Molecular Weight:
150.13
AlogP:
-2.58
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
0.0
Source:
ABC-008
1
Unknown
Investigational
Unknown
Unknown
Myositis, Inclusion Body
Unknown
ABC-008
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ANTI-SCLEROSTIN
1
Antibody
Investigational
Unknown
Unknown
Unknown
Sclerostin inhibitor
ANTI-SCLEROSTIN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IGM-8444
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
IGM-8444
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986318
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-986318
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG6029
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG6029
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CP-609754
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Neoplasms
Unknown
CP-609754
×
Maximum Phase:
1
First Approval:
None
UNII:
L0S47W9GPY
Molecule Type:
Small molecule
Molecular Formula:
C29H22ClN3O2
Molecular Weight:
479.97
AlogP:
4.86
PSA:
60.05
HBD:
1.0
HBA:
#RotB:
4.0
Source:
PROFILNINE SD
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PROFILNINE SD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
104
105
106
107
108
109
110
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA